课题基金 / 基金详情

Activation or inactivation mechanism of brain cdc2-like kinase, cdk5

Activation or inactivation mechanism of brain cdc2-like kinase, cdk5
脑cdc2样激酶cdk5的激活或失活机制
批准号:
09480191
负责人:
HISANAGA Shin-ichi
金额:
$8.45万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

HISANAGA Shin-ichi的其他基金

相似基金

相关文献

中文摘要
翻译
细胞周期蛋白依赖性激酶是真核细胞细胞周期进展的关键因素。 CDK5 是一种独特的 CDK,其激酶活性仅在有丝分裂后神经元中检测到。多项证据表明,CDK5 通过轴突细胞骨架(例如微管相关蛋白 tau 和神经丝)的磷酸化参与发育过程中的神经元迁移或定位。然而,尚不清楚其激酶活性是如何调节的。我们在这里研究了CDK5.1的激活或失活机制。我们以神经丝-H亚基的磷酸化为标记,研究了原代培养神经元中CDK5的激活机制。当磷酸化形式的神经丝-H亚基出现并发生突触形成时,CDK5在铺板后4至5天被激活。将 BDNF 添加到培养基中诱导 CDK5 的激活。这些结果表明CDK5的激活是由突触形成后BDNF分泌增加诱导的。2. CDK5 通过与仅在神经元中表达的激活亚基 p35 结合而被激活。 p35是一种寿命较短的蛋白质,在几个小时内就会降解减少。牛脑或猪脑。参与这种有限蛋白水解的蛋白酶被证明是钙蛋白酶。向猪脑提取物中添加 CaiD12 可诱导 p35 蛋白水解为 p25。这种蛋白水解作用被钙蛋白酶抑制剂抑制。蛋白水解改变了CDK5的溶解度。通过短暂离心沉淀的 P35/CDK5 在蛋白水解转化为 p25 后变得可溶。 p35 到 p25 的有限蛋白水解在神经元细胞死亡时增强。
英文摘要
Cyclin-dependent kinases are key factors in progression of cell cycle in eukaryotic cells. CDK5 is an unique CDK whosc kinase activity is detected only in post-mitotic neurons. Several lines of evidence suggest that CDK5 involves in neuronal migration or positioning during development via phosphorylation of axonal cytoskeletons such as microtubule-associated protein tau and neurofilaments. However, it is not known how its kinase activity is regulated. We investigated here the activation or inactivation mechanism of CDK5.1. We studied the activation mechanism of CDK5 in primary cultured neurons using the phosphorylation of neurofilament-H subunit as a marker. CDK5 was activated at 4 to 5 days after plating when phosphorylated form of neurofilament-H subunit appeared and synapse formation occurred. Addition of BDNF into culture medium induced activation of CDK5. These results suggest that activation of CDK5 was induced by increased secretion of BDNF after synapse formation.2. CDK5 is activated by binding to activating subunit p35 which is expressed in neurons exclusively. p35 is a short life protein degraded in a few hours. CDK5 decreased its activity along with degradation of p35. p35 was degraded by proteasome as well as cyclins in proliferating cells. Phosphorylation was suggested to be a signal for degradation.3. p35 is proteolysed to p25 during purification of CDK5 from bovine or porcine brains. Proteases involving in this limited proteolysis was shown to be calpain. Addition of CaィイD12+ィエD1 to porcine brain extract induced proteolysis of p35 to p25. This proteolysis was suppressed by calpain inhibitor. The proteolysis changed the solubility of CDK5. P35/CDK5 precipitated by brief centrifugation became to be soluble after proteolytic conversion to p25. Limited proteolysis of p35 to p25 was enhanced at the time of neuronal cell death.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
久永真市: "分子生物学 田沼靖一編、共著"丸善. 16 (1999)
Makoto Hisanaga:“田沼精一编辑和合着的分子生物学”Maruzen 16 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
久永真市: "ロータリーシャドウイング-繊維状蛋白の観察に優れたグリセリン・スプレイ法"細胞工学 16. 8 (1997)
Makoto Hisanaga:“旋转阴影 - 甘油喷雾法非常适合观察纤维蛋白”Cell Engineering 16. 8 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
斎藤太郎: "プロティンフォスファターゼによる中間径フィラメントの機能制御" 蛋白質・核酸・酵素. 43. 76-83 (1998)
Taro Saito:“蛋白质磷酸酶对中间丝的功能控制”《蛋白质/核酸/酶》43. 76-83 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Honma et al.: "Phosphorylation of retinablastoma protain at apoptptic cell death in rat neuroblastoma B50 cells"Neurosci.Lett.. 235. 45-48 (1997)
Honma 等:“大鼠神经母细胞瘤 B50 细胞凋亡时视网膜母细胞瘤蛋白的磷酸化”Neurosci.Lett.. 235. 45-48 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
32
    Regulation of endosome formation and recycling by Cdk5/p35 in neurons
    • 批准号:
      20370047
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.81万
    • 财政年份:
      2008
    • 负责人:
      HISANAGA Shin-ichi
    • 依托单位:
    Regulation of Cdk5 activity and function in neurons
    • 批准号:
      17300119
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.65万
    • 财政年份:
      2005
    • 负责人:
      HISANAGA Shin-ichi
    • 依托单位:
    The novel function of cyclin-dependent kinase 5, a role in long term potentiation
    • 批准号:
      14580703
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2002
    • 负责人:
      HISANAGA Shin-ichi
    • 依托单位:
    The regulation mechanism of degradation of p35 CDK5 activation subunit in neurons
    • 批准号:
      12680700
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.43万
    • 财政年份:
      2000
    • 负责人:
      HISANAGA Shin-ichi
    • 依托单位:
    国内基金
    海外基金
    基于力学微环境探讨ERK/CDK5/P-MIEF1轴阻滞AECII分化在肺纤维化中的作用及机制研究
    USP4/Fbxw7通过稳定CDK5促进线粒体裂变进而通过重塑谷氨酰胺代谢介导胃癌曲妥珠单抗耐药的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      黎晖
    • 依托单位:
    圣草酚靶向结合PSA稳定CDK5激活Nrf2信号抑制铁死亡的抗AD机制 研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      李文军
    • 依托单位:
    基于 CDK5/P35 信号通路探究脊髓水平去甲肾 上腺素能神经元调控慢性神经病理性疼痛潜 在的临床应用机制研究
    • 批准号:
      HZY24H090005
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      沈悦
    • 依托单位: